Current understanding of HIF in renal disease

Kidney and Blood Pressure Research

Volumn 28, Issue 5-6, 2006, Pages 325-340

  Rosenberger, Christian ^a   Rosen, Seymour ^b   Heyman, Samuel N ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HEBREW UNIVERSITY   (Israel)

Author keywords

Acute renal failure; Hypoxia inducible factors; p53; Prolyl hydroxylase inhibition; Renal interstitial fibrosis

Indexed keywords

CALCIUM CHELATING AGENT; CYCLOSPORIN A; DEFEROXAMINE; DIHYDRALAZINE; GLUTARIC ACID DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IMMUNOSUPPRESSIVE AGENT; IRON CHELATING AGENT; PIMONIDAZOLE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE INHIBITOR; PROTEIN INHIBITOR; PROTEIN P53; RAPAMYCIN; UNCLASSIFIED DRUG;

ACUTE GLOMERULONEPHRITIS; ACUTE KIDNEY FAILURE; CLINICAL TRIAL; DISEASE SEVERITY; FIBROSING ALVEOLITIS; GENE TARGETING; HUMAN; HYPOXIA; KIDNEY DISEASE; NEPHROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RENAL ARTERIOLOPATHY; REVIEW;

ANIMALS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; KIDNEY; KIDNEY DISEASES; OXYGEN CONSUMPTION;

EID: 33644976897     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090187     Document Type: Review

References (146)

1. Semenza GL, Wang GL: A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992;12:5447-5454.
2. 2 homeostasis. Curr Opin Genet Dev 1998;8:588-594.
3. Maxwell PH: HIF-1: An oxygen response sys3 tem with special relevance to the kidney. J Am Soc Nephrol 2003;14:2712-2722.
4. Ratcliffe PJ: From erythropoietin to oxygen: hypoxia-inducible factor hydroxylases and the hypoxia signal pathway. Blood Purif 2002;20:445-450.
5. 2- regulated gene expression. FASEB J 2002;16:1151-1162.
6. Bracken CP, Whitelaw ML, Peet DJ: The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Cell Mol Life Sci 2003;60:1376-1393.
7. Lando D, Gorman JJ, Whitelaw ML, Peet DJ: Oxygen-dependent regulation of hypoxia-inducible factors by prolyl and asparaginyl hydroxylation. Eur J Biochem 2003;270:781-790.
8. Lee JW, Bae SH, Jeong JW, Kim SH, Kim KW: Hypoxia-inducible factor (HIF-1)α: its protein stability and biologic functions. Exp Mol Med 2004;36:1-12.
9. Maxwell PH: HIF-1's relationship to oxygen: simple yet sophisticated. Cell Cycle 2004;3:156-159.
10. Metzen E, Ratcliffe PJ: HIF hydroxylation and cellular oxygen sensing. Biol Chem 2004;385:223-230.
11. Semenza GL: Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology 2004;19:176-182.
12. Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC: Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation. Mol Cell Biol 2003;23:9361-9374.
13. Warnecke C, Zaborowska Z, Kurreck J, Erdmann VA, Frei U, Wiesener M, Eckardt KU: Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J 2004;18:1462-1464.
14. 2 sensing. Science 2001;292:464-468.
15. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ: Targeting of HIFalpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001;292:468-472.
16. Mahon PC, Hirota K, Semenza GL: FIH-I : A novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptionalactivity. Genes Dev 2001;15:2675-2686.
17. Hewitson KS, McNeill LA, Riordan MV, Tian YM, Bullock AN, Welford RW, Elkins JM, Oldham NJ, Bhattacharya S, Gleadle JM, Ratcliffe PJ, Pugh CW, Schofield CJ: Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem 2002;277:26351-26355.
18. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwel PH, Pugh CW, Schofield CJ, Ratcliffe PJ: C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001;107:43-54.
19. Bruick RK, McKnight SL: A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001;294:1337-1340.
20. Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J: HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1 alpha in normoxia. EMBO J 2003;22:4082-4090.
21. Marxsen JH, Stengel P, Doege K, Heikkinen P, Jokilehto P, Wagner T, Jelkmann W, Jaakkola P, Metzen E: Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J 2004;381:761-767.
22. Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL, Pugh CW, Ratcliffe PJ, Gleadle JM: Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 2004;279:38458-38465.
23. Hirsilä M, Koivunen P, Günzler V, Kivirikko KI, Myllyharju J: Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 2003;78:30772-30780.
24. Lando D, Peet DJ, Gorman JJ; Whelan DA, Whitelaw ML, Bruick RK: FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 2002;16:1466-1471.
25. Koivunen P, Hirsilä M, Günzler V, Kivirikko KI. Myllyharju J: Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem 2004;279:9899-9904.
26. Mole DR, Schlemminger I, McNeill LA, Hewitson KS, Pugh CW, Ratcliffe PJ, Schofield CJ: 2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase. Bioorg Med Chem Lett 2003;13:2677-2680.
27. Hewitson KS, Schofield CJ: The HIF pathway as a therapeutic target. Drug Discovery Today 2004;9:704-711.
28. Ratan RR, Siddiq A, Aminova L, Lange PS, Langley B, Ayoub I, Gensert JA, Chavez J: Translation of ischemic preconditioning to the patient: prolyl hydroxylase inhibition and hypoxia inducible factor-1 as a novel target for stroke therapy. Stroke 2004;35(suppl):2687-2689.
29. Goldberg MA, Dunning SP, Bunn HF: Regulation of the erythropoietin gene: Evidence that the oxygen sensor is a heme protein. Science 1988;242:1412-1415.
30. Kivirikko KI, Myllyla R, Pihlajaniemi T: Protein hydroxylation: Prolyl 4-hydroxylase, an enzyme with four cosubstrates and a multi-functional subunit. FASEB J 1989;3:1609-1617.
31. Salnikow K, Donald SP, Bruick RK, Zhitkovich A, Phang JM, Kasprzak KS: Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J Biol Chem 2004;279:40337-40344.
32. Demidenko ZN, Rapisarda AM, Garayoa M, Giannakakou P, Melillo G, Blagosklonny M: Accumulation of hypoxia-inducible factor-1 is limited by transcription-dependent depletion. Oncogene 2005;24:4829-4838.
33. Greijer AE, van der Wall E: The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 2004;57:1009-1014.
34. Schmidt T, Zou J, Brüne B: HIF-1 and p53: communication of transcription factors under hypoxia. J Cell Mol Med 2004;8:423-431.
35. Suzuki H, Tomida A, Tsuruo T: Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia. Oncogene 2001;20:5779-5788.
36. Semenza GL: HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 2002;8(4 suppl):S62-S67.
37. 2 See what HIF can do! Ann Rheum Dis 2005;64:971-980.
38. Hellwig-Burgel T, Stiehl DP, Wagner AE, Metzen E, Jelkmann V: Review: Hypoxia-inducible factor-1 (HIF-1): A novel transcription factor in immune reactions. J Interferon Cytokine Res 2005;25:297-310.
39. Bardos J, Ashcroft M: Negative and positive regulation of HIF-1: a complex network. Biochim Biophys Acta 2005;1755:107-120.
40. Dutcher JP: Mammalian target of rapamycin inhibition. Clin Cancer Res 2004;10:6382S-6387S.
41. Fuller TF, Preise CE, Serkova N, Niemann CU, Olson JL, Feng S: Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 2003;76:1594-1599.
42. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L: IL-1b mediated up-regulation of HIF-1α via an NF-kB/COX2 pathway identifies HIF as a critical link between inflammation and oncogenesis. FASEB J 2003;17:2115-2117.
43. Jung Y, Isaacs JS, Lee S, Trepel J, Liu ZG, Neckers L: Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. Biochem J 2003;370(Pt 3):1011-1017.
44. Zhou J, Schmidt T, Brüne B: Tumor necrosis factor-α causes accumulation of a ubiquitinated form of hypoxia inducible factor-1α through a nuclear factor-kB-dependent pathway. Mol Biol Cell 2003;14:2216-2225.
45. Chen TH, Wang JF, Chan P, Lee HM: Angiotensin II stimulates hypoxia-inducible factor 1a accumulation in glomerular mesangial cells. Ann NY Acad Sci 2005;1042:286-293.
46. Alam H, Maizels ET, Park Y, Ghaey S, Feigert ZJ, Chandel NS, Hunzicker-Dunn M: Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/Akt/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J Biol Chem 2004;279:19431-19440.
47. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL: Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 2002;277:38205-38211.
48. Hirota K, Fukuda R, Takabuchi S, Kizaka-Kondoh S, Adachi T, Fukuda K, Semenza GL: Induction of hypoxia-inducible factor 1 activity by muscarinic acetylcholine receptor signaling. J Biol Chem 2004;279:41521-41528.
49. Kasuno K, Takabuchi S, Fukuda K, Kizaka-Kondoh S, Yodoi J, Adachi T, Semenza GL, Hirota K: Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling. J Biol Chem 2004;279:2550-2558.
50. 2 is mediated by hypoxia-inducible factor 1. Cancer Res 2003;63:2330-2334.
51. Ma Y, Freitag P, Zhou J, Brüne B, Frede S, Fandrey J: Thyroid hormone induces erythropoietin gene expression through augmented accumulation of hypoxia-inducible factor-1. Am J Physiol 2004;287:R600-R607.
52. Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA, Gutkind JS: The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res 2000;60:4873-4880.
53. Wakisaka N, Kondo S, Yoshizaki T, Murono S, Furukawa M, Pagano JS: Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha. Mol Cell Biol 2004;24:5223-5234.
54. Yoo YG, Oh SH, Park ES, ChoiH, Lee N, Park H, Kim DK, Yu DY, Seong JK, Lee MO: Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway. J Biol Chem 2003;278:39076-39084.
55. D'Angelo G, Duplan E, Vigne P, Frelin C: Cyclosporin A prevents the hypoxic adaptation by activating hypoxia-inducible factor-1α Pro-564 hydroxylation. J Biol Chem 2003;278:15406-15411.
56. Knowles HJ, Tian YM, Mole DR, Harris AL: Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1a, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases. Circ Res 2004;95:162-169.
57. Berchner-Pfannschmidt U, Petrat F, Doege K, Trinidad B, Freitag P, Metzen E, de Groot H, Fandrey J: Chelation of cellular calcium modulates hypoxia-inducible gene expression through activation of hypoxia-inducible factor-1α. J Biol Chem 2004;279:44976-44986.
58. Mansfield KD, Simon MS, Keith B: Hypoxic reduction in cellular glutathione levels requires mitochondrial reactive oxygen species. J Appl Physiol 2004;97:1358-1366.
59. Richard DE, Berra E, Pouyssegur J: Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J Biol Chem 2000;275:26765-26771.
60. Yang ZZ, Zhang AY, Yi FX, Li PL, Zou AP: Redox regulation of HIF-1alpha levels and HO-1 expression in renal medullary interstitial cells. Am J Physiol 2003;284:F1207-F1215.
61. Page EL, Robitaille GA, Pouyssegur J. Richard DE : Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J Biol Chem 2002;277:48403-48409.
62. Blouin CC, Page EL, Soucy GM, Richard DE: Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. Blood 2004;103:1124-1130.
63. Kodama T, Shimizu N, Yoshikawa N, Makino Y, Ouchida R, Okamoto K, Hisada T, Nakamura H, Morimoto C, Tanaka H: Role of the glucocorticoid receptor for regulation of hypoxia-dependent gene expression. J Biol Chem 2003;278:33384-33391.
64. O'Rourke JF, Pugh CW, Bartlett SM, Ratcliffe PJ: Identification of hypoxically inducible mRNAs in HeLa cells using differential-display PCR: role of hypoxia-inducible factor-1. Eur J Biochem 1996;241:403-410.
65. Eckhart AD, Yang N, Xin X, Faber JE: Characterization of the alpha1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle. Proc Natl Acad Sci USA 1997;94:9487-9492.
66. Cormier-Regard S, Nguyen SV, Claycomb WC: Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J Biol Chem 1998;273:17787-17792.
67. Wykoff CC, Pugh CW, Maxwell PH, Harris AL, Ratcliffe PJ: Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene 2000;19:6297-6305.
68. Chun YS, Hyun JY, Kwak YG, Kim IS, Kim CH, Choi E, Kim MS, Park JW: Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1. Biochem J 2003;370:149-157.
69. Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P, Semenza GL: Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 2003;63:1138-1143.
70. Semenza GL, Roth PH, Fang HM, Wang GL: Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994;269:23757-23763.
71. Yamakawa M, Liu LX, Date T, Belanger AJ, Vincet KA, Akita GY, Kuriyama T, Cheng SH, Gregory RJ, Jiang C: Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 2003;93:664-673.
72. Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S, Rowan A, Yan Z, Campochiaro PA, Semenza GL: Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003;93:1074-1081.
73. Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL: Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 2000;60:7075-7083.
74. Nishiyama J, Yi X, Venkatachalam MA, Dong Z: cDNA cloning and promoter analysis of rat caspase-9. Biochem J 2001;360:49-56.
75. Kong T, Eltzschig HK, Karhausen J, Colgan SP, Shelley CS: Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of b2 integrin gene expression. Proc Natl Acad Sci USA 2004;101:10440-10445.
76. Staller P, Sulitjova A, Lisztwan J, Moch H, Oakeley EJ, Krek W: Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003;425:307-311.
77. Battacharya S, Michels CL, Leung MK, Arany ZP, Kung AL, Livingston DM: Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1. Genes Dev 1999;13:64-75.
78. Mukhopadhyay CK, Mazumder B, Fox PL: Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J Biol Chem 2000;275:21048-21054.
79. Takahashi Y, Takahashi S, Shiga Y, Yoshimi T, Miura T: Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells. J Biol Chem 2000;275:14139-14146.
80. Higgins DE, Biju MP, Akai Y, Wutz A, Johnson RS, Haase VH: Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol 2004;287:F1223-F1232.
81. Goda N, Ryan HE, Khadivi B, McNulty W, Rickert RC, Johnson RS: Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol Cell Biol 2003;23:359-369.
82. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS: Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 2001;15:2865-2876.
83. Bazan NG, Lukiw WJ: Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells. J Biol Chem 2002;277:30359-30367.
84. Miyazaki K, Kawamoto T, Tanimoto K, Nishiyama M, Honda H, Kato Y: Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J Biol Chem 2002;277:47014-47021.
85. Sanchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabeu C: Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem 2002;277:43799-43808.
86. Hu J, Discher DJ, Bishopric NH, Webster KA: Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem Biophys Res Commun 1998;245:894-899.
87. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A: Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Cem 1996;271:32529-32537.
88. Oikawa M, Abe M, Kurosawa H, Hida W, Shirato K, Sato Y: Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. Biochem Biophys Res Commun 2001;289:39-43.
89. Yoon DY, Buchler P, Saarikoski ST, Hines OJ, Reber HA, Hankinson O: Identification of genes differentially induced by hypoxia in pancreatic cancer cells. Biochem Biophys Res Commun 2001;288:882-886.
90. Chen C, Pore N, Behrooz A, Imail-Beigi F, Maity A: Regulation of glut-1 mRNA by hypoxia-inducible factor-1: interaction between H-ras and hypoxia. J Biol Chem 2001;276:9519-9525.
91. Graven KK, Yu Q, Pan D, Roncarati JS, Farber HW: Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene. Biochim Biophys Acta 1999;1447:208-218.
92. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AM: Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 1997;272:5375-5381.
93. Mathupala SP, Rempel A, Pedersen PL: Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J Biol Chem 2001;276:43407-43412.
94. Lee MJ, Kim JY, Suk K, Park JH: Identification of the hypoxia-inducible factor 1 alpha-responsive HGTD-P gene as a mediator in the mitochondrial apoptotic pathway. Mol Cell Biol 2004;24:3918-3927.
95. Del Peso L, Castellanos MC, Temes E, Martin-Pulg S, Cuevas Y, Olmos G, Landazuri MO: The von-Hippel-Lindau/hypoxia inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J Biol Chem 2003;278:48690-48695.
96. Melillo G, Taylor LS, Brooks A, Musso T, Cox GW, Varesio L: Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J Biol Chem 1997;272:12236-12243.
97. Löfstedt T, Jogi A, Sigvardson M, Gradin K, Poellinger L, Pahlman S, Axelson H: Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells. J Biol Chem 2004;279:39223-39231.
98. Feldser D, Agani G, Iyer NV, Pak B, Ferreira G, Semenza GL: Reciprocal positive regulation of hypoxia-inducible factor-1 alpha and insulin-like growth factor2. Cancer Res 1999;59:3915-3918.
99. Furuta GT, Turner JR, Taylor CT, Hershberg RM, Comerford K, Narravula S, Podolski DK, Colgan SP: Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 2001;193:1027-1034.
100. Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Pouyssegur J, Guerre-Millo M: Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 2002;277:42953-42957.
101. Comerford KM, Wallace JT, Karhausen J, Louis NA, Montalto MC, Colgan SP: Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 2002;62:3387-3394.
102. Bruick RK: Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 2000;97: 9082-9087.
103. Sowter HM, Ratcliffe PJ, Watson P, Greenberg AH, Harris AL: HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 2001;61:6669-6673.
104. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, Hansen KR, Thompson LF, Colgan SP: Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 2002;110:993-1002.
105. Narravula S, Colgan SP: Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J Immunol 2001;166:7543-7548.
106. Erratum in J Immunol 2002;68:3113.
107. Belanger AJ, Lu H, Date T, Liu LX, Vincent KA, Akita GY, Cheng SH, Gregory RJ, Jiang C: Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1alpha. J Mol Cell Cardiol 2002;34:765-774.
108. Minchenko A, Leshchinski I, Opentanova I, Sang N, Srinivas V, Armstead V, Caro J: Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem 2002;277:6183-6187.
109. Kietzmann T, Roth U, Jungermann K: Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 1999;94:4177-4185.
110. Lukiw WJ, Gordon WC, Rogaev EI, Thompson H, Bazan NG: Presenilin-2 (PS2) expression up-regulation in a model of retinopathy of prematurity and pathoangiogenesis. Neuroreport 2001;12:53-57.
111. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller GA, Peale F, Gurney A, Hillan KJ, Ferrara N: Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001;412:877-884.
112. Shoshani T, Faerman A, Mett I, Zelin E, Tenne T, Gorodin S, Moshel Y, Elbaz S, Budanov A, Chajut A, Kalinski H, Kamer I, Rozen A, Mor O, Keshet E, Leshkowitz D, Einat P, Skaliter R, Feinstein E: Identification of a novel hypoxia-inducible factor 1 -responsive gene, RTP801, involved in apoptosis. Mol Cell Biol 2002;22:2283-2293.
113. Chauvet C, Bois-Joyeux B, Berra E, Pouyssegur J, Danan JL: The gene encoding human retinoic acid-receptor-related orphan receptor alpha is a target for hypoxia-inducible factor 1. Biochem J 2004;384:79-85.
114. Leonard MO, Cottel DC, Godson C, Brady HR, Taylor CT: The role of HIF-1 alpha in transcriptional regulation of the proximal tubular epithelial cell response to hypoxia. J Biol Chem 2003;278:40296-40304.
115. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC: Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10:858-864.
116. Rolfs A, Kvietikova I, Gassmann M, Wenger RH: Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J Biol Chem 1997;272:20055-20062.
117. Lok CN, Ponka P: Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem 1999;274:24147-24152.
118. Scheid A, Wenger RH, Schaffer L, Camenisch I, Distler O, Ferenc A, Cristina H, Ryan HE, Johnson RS, Wagner KF, Stauffer UG, Bauer C, Gassmann M, Meuli M: Physiologically low oxygen concentrations in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor-beta3. FASEB J 2002;16:411-413.
119. Gess B, Hofbauer KH, Deutzmann R, Kurtz A: Hypoxia up-regulates triosephosphate isomerase expression via a HIF-dependent pathway. Pfluegers Arch 2004;448:175-180.
120. 2-responsive sequences on the tyrosine hydroxylase gene. J Biol Chem 1995;270:23774-23779.
121. Estes SD, Stoler DL, Anderson GR: Anoxic induction of sarcoma virus-related VL30 retrotransposon is mediated by cis-acting element which binds hypoxia-inducible factor 1 and an anoxia-inducible factor. J Virol 1995;69:6335-6341.
122. Liu Y, Cox SR, Morita T, Kourembanas S: Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ Res 1995;77:638-643.
123. Gerber HP, Condorelli F, Park J, Ferrara N: Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is upregulated by hypoxia. J Biol Chem 1997;272:23659-23667.
124. Wagner KD, Wagner N, Wellmann S, Schley G, Bondke A, Theres H, Scholz H: Oxygen-regulated expression of the Wilms' tumor suppressor Wt1 involves hypoxia-inducible factor-1 (HIF-1). FASEB J 2003;17:1364-1366.
125. Sasaki R, Masuda S, Nagao M: Pleiotropic and tissue-specific expression of erythropoietin. News Physiol Sci 2001;16:110-113.
126. Baker JE: Erythropoietin mimics ischemic preconditioning. Vasc Pharmacol 2005;42: 233-241.
127. Joyeux-Faure M, Godin-Ribuot D, Ribuot C: Erythropoietin and myocardial protection: What's new? Fundamental Clin Pharmacol 2005;19:439-446.
128. Kietzmann T, Knabe W, Schmidt-Kastner R: Hypoxia and hypoxia-inducible factor modulated gene expression in brain: involvement in neuroprotection and cell death. Eur Arch Psychiatry Clin Neurosci 2001;251:170-178.
129. Maiese K, Li F, Chong ZZ: New avenues of exploration for erythropoietin. JAMA 2005;293:90-95.
130. Bahlmann FH, Song R, Boehm SM, Mengel M, von Wasielewski R, Lindschau C, Kirsch T, de Groot K, Laudeley R, Niemczyk E, Guler F, Menne J, Haller H, Fliser D: Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 2004;110:1006-1012.
131. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Fowler III AA, Kukreja RC: HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in mod3 ulating microvascular chemokine generation. Am J Physiol 2005;289:H542-H548.
132. Otterbein LE, Choi AMK: Heme oxygenase: colors of defense against cellular stress. Am J Physiol 2000;279:L1029-L1037.
133. Xi L, Taller M, Yin C, Salloum F, Kukreja RC: Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1alpha and AP-1 and iNOS signaling. Am J Physiol 2004;287:H2369-H2375.
134. Zou AP, Cowley AW Jr: Reactive oxygen species and molecular regulation of renal oxygenation. Acta Physiol Scand 2003;179:233-241.
135. Stroka D. Burkhard T, Desbaillets I, Wenger RH, Neil DAH, Bauer C, Gassmann M, Candinas D: HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 2001;15:2445-2453.
136. Zou AP, Yang ZZ, Li PL, Cowley AW Jr: Oxygen-dependent expression of hypoxia-inducible factor-1a in renal medullary cells of rats. Physiol Genom 2001;6:159-168.
137. Rosenberger C, Mandriota S, Juergensen JS, Wiesener MS, Hoerstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, Eckardt KU: Expression of hypoxia-inducible factor-1 alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 2002;13:1721-1732.
138. Rosenberger C, Griethe W, Gruber G, Wiesener MS, Frei U, Bachmann S, Eckardt KU: Cellular responses to hypoxia after renal segmental infarction. Kidney Int 2003;64:874-886.
139. Yuan HAT, Li XZ, Pitera JE, Long DA, Woolf AS: Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-a and hypoxia-inducible factor-1a. Am J Pathol 2003:163:2289-2301.
140. Monotham K, Tanaka T, Matsumoto M, Ohse T, Miyata T, Inagi R, Kurokawa K, Fujita T, Nangaku M: Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol 2004;15:1277-1288.
141. Wang PX, Sanders PW: Mechanism of hypertensive nephropathy in the Dahl/Rapp rat: a primary disorder of vascular smooth muscle. Am J Physiol 2004;288:236-242.
142. Rosenberger C, Heyman SN, Rosen S, Shina A, Goldfarb M, Griethe W, Frei U, Reinke P, Bachmann S, Eckardt KU: Up-regulation of HIF in experimental acute renal failure: evidence for a protective transcriptional response to hypoxia. Kidney Int 2005;67:531-542.
143. Monotham K, Tanaka T, Ohse T, Kojima I, Miyata T, Inagi R, Tanaka H, Sassa R, Fujita T, Nangaku M: A biologic role of HIF-1 in the renal medulla. J Am Soc Nephrol 2005;67:1428-1439.
144. Kairaitis LK, Wang Y, Gassmann M, Tay YC, Harris DCH: HIF-1a expression follows microvascular loss in advanced murine adriamycin nephrosis. Am J Physiol 2005;288: F198-F206.
145. Kudo Y, Kakinuma Y, Mori Y, Morimoto N, Karashima T, Furihata M, Sato T, Shuin T, Sugiura T: Hypoxia-inducible factor-1α is involved in the attenuation of experimentally induced rat glomerulonephritis. Exp Nephrol 2005;100:e95-e103.
146. Bachmann S, Le Hir M, Eckardt KU: Co-localization of erythropoietin mRNA and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 1993;41:335-341.